Status:
COMPLETED
To Find Out Whether Valsartan With or Without Other Blood Pressure Medications Would Improve the Ability of the Heart to Fill and Empty, and the Ability of the Heart Muscle to Relax Adequately in People With High Blood Pressure.
Lead Sponsor:
Novartis
Conditions:
Diastolic Dysfunction
Hypertension
Eligibility:
All Genders
45+ years
Phase:
PHASE4
Brief Summary
Patients who have had high blood pressure for a long time may have diastolic dysfunction. Diastolic Dysfunction is when your heart has difficulty filling and emptying, and relaxing adequately. This s...
Eligibility Criteria
Inclusion
- Diagnosis/History of high blood pressure
- Male or Female age 45 years or older
Exclusion
- History of stroke, transient ischemic attack or heart attack within the last 6 months
- A hospital admission for congestive heart failure within the last year
- Use of certain high blood pressure medications such as ACE inhibitors, Angiotensin Receptor Blockers or aldosterone antagonists or other agents that may work in the same pathway (RAAS) as valsartan within the past 3 months.
- Other protocol-defined exclusion criteria may apply.
Key Trial Info
Start Date :
August 1 2004
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
June 1 2006
Estimated Enrollment :
317 Patients enrolled
Trial Details
Trial ID
NCT00170924
Start Date
August 1 2004
End Date
June 1 2006
Last Update
November 8 2011
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Novartis Pharmaceuticals
East Hanover, New Jersey, United States, 07936